Zevra Therapeutics, Inc. (ZVRA)
8.45
-0.13
(-1.52%)
USD |
NASDAQ |
Dec 10, 16:00
8.57
+0.12
(+1.42%)
After-Hours: 20:00
Zevra Therapeutics Total Liabilities (Quarterly): 136.95M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Nektar Therapeutics | 216.26M |
| XOMA Royalty Corp. | 155.19M |
| Akebia Therapeutics, Inc. | 322.56M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
| Palatin Technologies, Inc. | 8.218M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 270.12M |
| Shareholders Equity (Quarterly) | 133.16M |
| Debt to Equity Ratio | 0.471 |
| Current Ratio | 8.621 |
| Net Debt Paydown Yield | -0.12% |